🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A3D is a phase I/II clinical trial. The primary objective is to evaluate th...
Status
Recruiting
Location
University Hospital of Toulouse
Start Date
2026-05-07
Trial ID
NCT07367815
The goal of this clinical trial is to learn if tumor neoantigen-specific T ...
Status
Unknown
Location
Nanjing Jinling Hospital
Start Date
2024-04-18
Trial ID
NCT06431529
Treatments Being Tested
This is a single-center, open-label, phase I study designed to determine th...
Status
Terminated
Location
Froedtert & the Medical College of Wisconsin
Start Date
2022-10-31
Trial ID
NCT05325281
Alemtuzumab is an antibody that reduces the strength of the immune system t...
Status
Recruiting
Location
Cincinnati Children's Hospital Medical Center
Start Date
2023-01-11
Trial ID
NCT05501756
Treatments Being Tested
The goal of this interventional clinical trial is to compare the efficacy o...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-02-24
Trial ID
NCT07413146
This single arm pilot phase I study with safety run-in is designed to estim...
Status
Recruiting
Location
Washington University School of Medicine
Start Date
2022-11-03
Trial ID
NCT05011422
Treatments Being Tested
SURF is a randomised controlled, parallel group, single blind phase II stud...
Status
Recruiting
Location
Assistance Publique Hopitaux de Marseille
Start Date
2024-03-13
Trial ID
NCT05857371
Treatments Being Tested
RATIONALE: Zoledronic acid, vitamin D, and calcium may prevent bone loss in...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2005-07
Trial ID
NCT00321932
Treatments Being Tested
This study seeks to determine if administration of the drug belumosudil (KD...
Status
Active Not Recruiting
Location
University of California, Los Angeles
Start Date
2023-07-07
Trial ID
NCT05806749
Treatments Being Tested
This is a Phase 1/2, study evaluating IOV-2001 (Adoptive Cell Therapy) comp...
Status
Completed
Location
Moffitt Cancer Center
Start Date
2020-02-19
Trial ID
NCT04155710
Treatments Being Tested